Paliperidone is an atypical antipsychotic agent of the benzisoxazole class, widely indicated for the treatment of schizophrenia and schizoaffective disorder. Its therapeutic activity is primarily mediated… Read more




![Chemical structure of Tetradecanoic Acid 3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4-oxo-4H-pyrido[1,2a]pyrimidin-9-yl ester](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1172995-11-7-Tetradecanoic-Acid-3-2-4-6-Fluoro-12-benzisoxazol-3-yl-1-piperidinylethyl-6789-tetrahydro-2-methyl-4-oxo-4H-pyrido12apyrimidin-9-yl-ester.png&w=3840&q=75)
Paliperidone is an atypical antipsychotic agent of the benzisoxazole class, widely indicated for the treatment of schizophrenia and schizoaffective disorder. Its therapeutic activity is primarily mediated through the antagonism of central dopamine D2 and serotonin 5-HT2A receptors. In pharmaceutical analysis, the related compounds, including pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope labelled standards, are essential tools for ensuring product quality and safety. Laboratories utilize these high-quality materials for comprehensive impurity profiling, method development, and the validation of analytical procedures such as HPLC and LC-MS/MS. Stable isotope labelled versions of Paliperidone are particularly valuable as internal standards in quantitative analysis to improve accuracy and reproducibility. By employing these reference standards, researchers can effectively characterize degradation pathways, monitor process-related impurities, and maintain rigorous quality control throughout the pharmaceutical development and batch release lifecycle.